SCHULER JACK W 4

What Happened
Jack W. Schuler, a 10% owner of Biodesix (BDSX), made open-market purchases totaling 100,000 shares. He acquired 80,000 shares on 2026-01-23 at a weighted average price of $11.81 (total reported $944,672) and 20,000 shares on 2026-01-26 at a weighted average price of $11.80 (total reported $236,064). These were purchases (code P), which are direct buys rather than sales.

Key Details

• Transaction dates and reported prices:
  • 2026-01-23 — 80,000 shares @ weighted avg $11.81 (total $944,672). Footnote F1: actual prices ranged $11.225–$12.05.
  • 2026-01-26 — 20,000 shares @ weighted avg $11.80 (total $236,064). Footnote F3: actual prices ranged $11.56–$11.99.
• Total acquired: 100,000 shares for about $1,180,736 (sum of reported totals).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Insider role / authority: Schuler is reported as a 10% owner and is sole trustee of the Jack W. Schuler Living Trust (F2) and the Jack W. Schuler 2025 GRAT (F4).
• Timeliness: Filing date 2026-01-27 appears to meet the 2-business-day Form 4 deadline for the Jan 23 and Jan 26 trades (filed promptly).

Context

• These were straightforward open-market purchases by a significant shareholder (10% owner). Purchases by insiders are often viewed as a positive signal but do not prove future performance; no motivation is stated in the filing.
• Footnotes indicate weighted-average prices and that the trades occurred in multiple transactions across price ranges; the reporting person can provide per-trade price details on request.